As founding chairman and president of Missouri Cures, Mr. Rubin led the successful passage of the Missouri Stem Cell Research Initiative, or “Amendment 2” to the Missouri Constitution, approved by voters in what the Washington Post called the nation’s “emblematic election” of 2006. Mr. Rubin continues to lead Missouri Cures and its education foundation in advancing medical research and pro-science policies in Missouri.
As founding President & CEO of BioSTL, Donn Rubin helps lead systemic change for St. Louis, bringing new economic vitality and a transformational entrepreneurial culture that leverages the region’s world-class strengths in innovation, especially the medical and plant biosciences. BioSTL is a non-profit civic coalition of university, business, and philanthropic leaders that ensure St. Louis has the financial, physical, policy and talent assets to support a dynamic bioscience and innovation ecosystem.
Mr. Rubin co-founded the Innovation Advocacy Counsel which promotes federal policy with Congress and Federal agencies that advances U.S. leadership in innovation and related economic growth. Rubin has served under Republican and Democratic Governors of Missouri as a director (and as Chairman, 2005 – 2008) of the Missouri Technology Corporation, charged by the General Assembly with leading the state’s innovation-based economic strategy.
Mr. Rubin has provided leadership to many civic and non-profit organizations. He was named a “Pillar of the Community” in 2010 for contributions to the St. Louis region. The St. Louis Business Journal has named him among the “Most Influential St. Louisans” numerous times, and ALIVE Magazine recognized Rubin in 2015 as one of the “Bold Minds Creating a Better St. Louis.”
Mr. Rubin received his B.S. in Economics, summa cum laude, from the Wharton School of the University of Pennsylvania; and his J.D., cum laude, from the University of Michigan Law School.